Showing results (201-210 of 245) with videos related to
Sort By:
Pageof 25
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injuryA R Almeida, D Bunnachak, M Burnier, et al.Microvascular Research|September 27, 2012
Potassium restores vasorelaxation of resistance arterioles in non-hypertensive DOCA/salt fed miceC Wyss, Q Wang, D Golshayan, et al.Investigative Ophthalmology & Visual Science|April 1, 1985
Experimental guinea pig ocular infection by Salmonella typhimuriumR Belfort, M R Toledo, M Burnier, et al.Journal of Cardiovascular Pharmacology|March 10, 2000
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers. p6M P Maillard, J Rossat, J Nussberger, et al.Ophthalmology|December 22, 1999
Orbital infarction and melting in a patient with systemic lupus erythematosusB P Arthurs, M K Khalil, F Chagnon, et al.Journal of Hypertension|July 1, 1995
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertensionB Favrat, M Burnier, J Nussberger, et al.Journal of Clinical Pharmacology|August 1, 1997
Sinistrin clearance for determination of glomerular filtration rate: a reappraisal of various approaches using a new analytical methodT Buclin, A Pechère-Bertschi, R Séchaud, et al.Journal of Cardiovascular Pharmacology|February 1, 1990
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibitionV Mooser, J Nussberger, L Juillerat, et al.Peptides|January 1, 1994
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissueE Grouzmann, G Alvarez-Bolado, C Meyer, et al.International Journal of Clinical Practice|November 25, 2010
Effects on blood pressure and cardiovascular risk of variations in patients' adherence to prescribed antihypertensive drugs: role of duration of drug actionA Lowy, V C Munk, S H Ong, et al.Pageof 25